194 related articles for article (PubMed ID: 31002103)
1. Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD).
Bandurska E; Damps-Konstańska I; Popowski P; Jędrzejczyk T; Janowiak P; Świętnicka K; Zarzeczna-Baran M; Jassem E
Med Sci Monit; 2019 Apr; 25():2879-2885. PubMed ID: 31002103
[TBL] [Abstract][Full Text] [Related]
2. Impact of Integrated Care Model (ICM) on Direct Medical Costs in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD).
Bandurska E; Damps-Konstańska I; Popowski P; Jędrzejczyk T; Janowiak P; Świętnicka K; Zarzeczna-Baran M; Jassem E
Med Sci Monit; 2017 Jun; 23():2850-2862. PubMed ID: 28603270
[TBL] [Abstract][Full Text] [Related]
3. Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD.
Jain VV; Allison R; Beck SJ; Jain R; Mills PK; McCurley JW; Van Gundy KP; Peterson MW
Respir Med; 2014 Dec; 108(12):1794-800. PubMed ID: 25294691
[TBL] [Abstract][Full Text] [Related]
4. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
[TBL] [Abstract][Full Text] [Related]
5. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
Jahnz-Rózyk K; Targowski T; From S
Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
[TBL] [Abstract][Full Text] [Related]
7. Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD.
Coughlin S; Peyerl FW; Munson SH; Ravindranath AJ; Lee-Chiong TL
Value Health; 2017 Mar; 20(3):379-387. PubMed ID: 28292482
[TBL] [Abstract][Full Text] [Related]
8. Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study.
Lisspers K; Johansson G; Jansson C; Larsson K; Stratelis G; Hedegaard M; Ställberg B
Respir Med; 2014 Sep; 108(9):1345-54. PubMed ID: 25002194
[TBL] [Abstract][Full Text] [Related]
9. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
10. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
Moll K; Sun SX; Ellis JJ; Howe A; Amin A
Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
[TBL] [Abstract][Full Text] [Related]
11. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
14. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada.
Poder TG; Carrier N; Bélanger M; Couillard S; Courteau J; Larivée P; Vanasse A
Int J Chron Obstruct Pulmon Dis; 2018; 13():3065-3076. PubMed ID: 30349220
[TBL] [Abstract][Full Text] [Related]
16. Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.
Hofer F; Achelrod D; Stargardt T
Appl Health Econ Health Policy; 2016 Dec; 14(6):691-701. PubMed ID: 27475635
[TBL] [Abstract][Full Text] [Related]
17. The impact of home hospitalization on healthcare costs of exacerbations in COPD patients.
Puig-Junoy J; Casas A; Font-Planells J; Escarrabill J; Hernández C; Alonso J; Farrero E; Vilagut G; Roca J
Eur J Health Econ; 2007 Dec; 8(4):325-32. PubMed ID: 17221178
[TBL] [Abstract][Full Text] [Related]
18. Direct costs of chronic obstructive pulmonary disease among managed care patients.
Dalal AA; Christensen L; Liu F; Riedel AA
Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():341-9. PubMed ID: 21037958
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the economic and patient outcome impact of an integrated COPD service in east London.
Garner A; Hodson M; Ketsetzis G; Pulle L; Yorke J; Bhowmik A
Int J Chron Obstruct Pulmon Dis; 2017; 12():1653-1662. PubMed ID: 28652718
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.
Khoudigian-Sinani S; Kowal S; Suggett JA; Coppolo DP
Int J Chron Obstruct Pulmon Dis; 2017; 12():3065-3073. PubMed ID: 29089755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
